Korro Bio, Inc. (KRRO) — Stock Score Summary

Korro Bio, Inc. (KRRO) has a MoatMap StockRank of 13/100 based on Quality (21/100), Value (39/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL. Korro Bio is a pre-clinical RNA editing company. Although its science may be promising, it lacks the commercialized products, pricing power, and high ROIC required by our Terry Smith and Warren Buffett lenses.

Korro Bio, Inc. is a biotechnology company pioneering the development of RNA editing therapies for serious diseases, utilizing its proprietary OPERA™ platform. The company operates at the cutting edge of genetic medicine, aiming to precisely modify RNA to create therapeutic proteins without altering the underlying DNA. Korro Bio is a preclinical-stage biopharmaceutical company focused on a novel and potentially transformative therapeutic modality, representing a high-risk, high-reward investment in the gene editing space.

Key Financial Metrics

Price$10.94
Market Cap$193M
P/E (Forward)-2.22
Price/Book1.35
Return on Equity-87.8%
Return on Invested Capital-86.0%
Debt/Equity35.85
Gross Margin0.0%
Operating Margin-2154.0%
Free Cash Flow$-39M

Korro Bio, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Korro Bio, Inc.’s (KRRO) StockRank?
MoatMap’s StockRank for Korro Bio, Inc. (KRRO) is 13/100, with a Strong Sell signal. It is a composite of Quality (21), Value (39), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Korro Bio, Inc. have an economic moat?
Korro Bio, Inc. (KRRO) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Korro Bio, Inc. a buy, hold, or sell?
MoatMap’s current signal for Korro Bio, Inc. (KRRO) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Korro Bio, Inc. in?
Korro Bio, Inc. (KRRO) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksKRRO deep dive reportAI ChampionsHow we score stocksSense-check another stock